CENTOGENE N.V. EO -,12CENTOGENE N.V. EO -,12CENTOGENE N.V. EO -,12

CENTOGENE N.V. EO -,12

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪10.49 M‬EUR
−1.2420EUR
‪−34.80 M‬EUR
‪47.54 M‬EUR
‪11.76 M‬
Beta (1Y)
2.12

About Centogene N.V.

CEO
Kim Stratton
Headquarters
Rostock
Employees (FY)
493
Founded
2018
ISIN
NL0014040206
FIGI
BBG00QT69C47
Centogene NV is a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. It operates through the following segments: Pharmaceutical, Diagnostics, and Corporate. The Pharmaceutical segment provides solutions to pharmaceutical partners, including target discovery, early patient recruitment and identification, epidemiological insights, and biomarker discovery. The Diagnostics segment offers genetic sequencing and diagnostics services to clients, who are typically physicians, laboratories, or hospitals, either directly or through distributors. The Other segment covers COVID-19 testing services to clients. The company was founded by Arndt Rolf and Christoph Ehlers in 2006 and is headquartered in Rostock, Denmark.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange CENTOGENE N.V. EO -,12 stocks are traded under the ticker 39K.
39K reached its all-time high on Mar 19, 2020 with the price of 31.0000 EUR, and its all-time low was 0.3000 EUR and was reached on Jun 3, 2024. View more price dynamics on 39K chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track CENTOGENE N.V. EO -,12 financials in yearly and quarterly reports right on TradingView.
CENTOGENE N.V. EO -,12 is going to release the next earnings report on Sep 4, 2024. Keep track of upcoming events with our Earnings Calendar.
39K net income for the last half-year is ‪−10.85 M‬ EUR, while the previous report showed ‪−24.23 M‬ EUR of net income which accounts for 55.20% change. Track more CENTOGENE N.V. EO -,12 financial stats to get the full picture.
No, 39K doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 24, 2024, the company has 493.00 employees. See our rating of the largest employees — is CENTOGENE N.V. EO -,12 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CENTOGENE N.V. EO -,12 EBITDA is ‪−32.78 M‬ EUR, and current EBITDA margin is −64.93%. See more stats in CENTOGENE N.V. EO -,12 financial statements.
Like other stocks, 39K shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CENTOGENE N.V. EO -,12 stock right from TradingView charts — choose your broker and connect to your account.